Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.
about
Treatment of Cushing disease: overview and recent findingsComorbidities in Cushing's diseaseEffects of Cushing disease on bone mineral density in a pediatric populationMutiple Spontaneous Rib Fractures in Patient with Cushing's Syndrome.Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelinePediatric DXA: clinical applications.Osteoporosis: recommendations for resistance exercise and supplementation with calcium and vitamin D to promote bone health.Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.Endocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism?Cushing's syndrome: aftermath of the cure.Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.Skeletal involvement in adult patients with endogenous hypercortisolism.Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study.Insights on accelerated skeletal repair in Cushing's disease.Corticosteroid-induced osteoporosis: an update for dermatologists.Clinical consequences of Cushing's syndrome.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Managing Cushing's disease: the state of the art.Cushing's disease: the burden of illness.Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease.Fracture risk assessment before and after resolution of endogenous hypercortisolism: is the FRAX® algorithm useful?Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
P2860
Q24626819-7D71CC2A-EF69-4EB5-BA39-63D3B3582F19Q27010491-5518E7CC-73C9-4B3D-885F-5F299C1611A3Q33872632-1F7D3EC9-84C8-4C96-82B0-40DD2F738E19Q34627986-43383E8B-5118-4987-ABBF-E62B2726B276Q35916555-41A82BE0-8D66-4DA9-A51A-5654D91BEFA1Q35944667-B236B4E0-3E09-4150-B740-60F373DF6107Q36634287-FB396337-129C-4D88-ABE9-CDCFD4984870Q36800875-E2240440-FED1-4375-A022-9137081AFB3EQ36940053-E121EA4F-CAD4-452E-9E16-2C05B02DD3A1Q37062081-6C830EAA-1AA2-472F-967B-808783F979D9Q37072338-1D01FCC5-6223-433B-9DD6-5BABECF401C8Q37133892-BFDDF826-900C-4C4B-9BB1-93E65C7DF1D4Q37508039-969392B1-AD6B-4F94-A8BF-7668237D1C9FQ37720400-101A7A23-D74A-4158-8694-8FD179BDC946Q37990943-4CFC7841-F1AF-4EE5-AE35-DE45A9B81F26Q38004913-86EF4CB6-E118-41FE-9BB4-DA2F5970B798Q38015162-0B6F5B7C-AEE0-4BCA-8916-052023D2076CQ38177740-56F10B40-BEB2-4294-B344-BA8B90055AB5Q38836721-319D0DAB-E9CB-49D5-80EC-5B3708369F7FQ45045554-650B151B-3CDF-40B7-9B02-D6F49E98F340Q46542918-194957E2-7CF7-441F-B372-68E5F0983DB9Q46561872-630B80B3-8FF0-4C6D-A0F9-93B311653AC1Q59043920-99279CAA-15D0-4D00-9990-ABAEAEEFD7E8
P2860
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of 2 years of cortisol ...... disease: a prospective study.
@en
Effect of 2 years of cortisol ...... disease: a prospective study.
@nl
type
label
Effect of 2 years of cortisol ...... disease: a prospective study.
@en
Effect of 2 years of cortisol ...... disease: a prospective study.
@nl
prefLabel
Effect of 2 years of cortisol ...... disease: a prospective study.
@en
Effect of 2 years of cortisol ...... disease: a prospective study.
@nl
P2860
P50
P921
P1476
Effect of 2 years of cortisol ...... disease: a prospective study.
@en
P2093
Michele Klain
Sandro Loche
P2860
P304
P356
10.1046/J.1365-2265.2003.01713.X
P50
P577
2003-03-01T00:00:00Z